美国对乙氨基毒性的N-乙半氨酸剂量的实践模式
Michael C Thomas1, Christopher J Edwards2, Amanda Dunlap1
1Samford University McWhorter School of Pharmacy, Birmingham, Alabama.
Innovations in pharmacy
|May 22, 2025
概括
虽然FDA批准的静脉注射n-乙半氨酸 (NAC) 疗法对于乙氨基毒性是常见的,但许多美国医院使用了更简单的替代方案. 这些变化优先考虑了安全性和易用性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床毒理学 临床毒理学
- 医院实践 医院实践
背景情况:
- 美国食品和药物管理局批准的静脉注射n-乙半氨酸 (NAC) 疗法用于乙氨基毒性,涉及三袋协议.
- 已经开发出了更简单,更替代的NAC方案,有可能减少错误和不良影响.
- 美国医院采用替代NAC治疗方案的患病率和原因尚不清楚.
研究的目的:
- 调查当前的实践模式,以管理美国医院的乙氨基毒性.
- 了解采用替代静脉注射n-乙半氨酸 (NAC) 疗法背后的采用率和动机.
主要方法:
- 一个经过试点测试的电子调查被分发给美国各地的住院项目主管.
- 该调查收集了与乙氨基毒性管理相关的人口和实践模式的数据.
- 用描述性统计数据来分析收集的调查数据.
主要成果:
- 总共收到了119个回复,代表了9.2%的回复率.
- 近三分之二的受访者使用了FDA批准的NAC疗法,而其他人则采用了替代方案.
- 转向替代疗法的主要原因包括简单性,减少错误和中毒中心的建议. 超过三分之一的人没有使用最大剂量.
结论:
- 静脉注射的n-乙半氨酸 (NAC) 主要通过FDA批准的治疗方案用于乙氨基毒性.
- 一些机构正在实施替代性静脉注射NAC疗法,以提高安全性和简单性为动力.
- 剂量重量上限是常见的,但不是普遍适用的,一些机构不使用最大值.
相关概念视频
01:22Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
125
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
125
01:14Prevention of Further Absorption of Poison
777
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
777
01:26Enhanced Elimination of Poison
468
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
468
01:26Anticholinesterase Agents: Poisoning and Treatment
767
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
767
01:11Renal Failure: Dose Adjustments
52
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
52
01:17Antidotes
603
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
603